Our results demonstrated a gradual decrease of USP10 level following ischaemic stroke, while this level was upregulated by VNS treatment resulting in reduced cerebral infarct volume and alleviated neurological deficits; however, this protective effect was blocked by USP10 silencing. This evidence concerns the gene USP10 and cerebral infarction.